Dianthus Therapeutics (DNTH) Non Operating Income (2022 - 2025)

Dianthus Therapeutics' Non Operating Income history runs 4 years deep, the most recent figure standing at $3.5 million for Q3 2025.

• In Q3 2025, Non Operating Income fell 25.45% year-over-year to $3.5 million; the TTM figure through Sep 2025 stood at $14.0 million (down 11.69% YoY), while the FY2024 annual figure was $16.9 million, up 265.77% from the prior year.
• Non Operating Income for Q3 2025 stood at $3.5 million, up from $3.3 million in the prior quarter.
• The five-year high for Non Operating Income was $4.7 million in Q3 2024, with the low at $470000.0 in Q3 2022.
• The 4-year median for Non Operating Income is $3.3 million (2025), against an average of $2.5 million.
• The sharpest annual moves came in 2024 and 2025: Non Operating Income surged 622.8% in 2024, then slipped 28.26% in 2025.
• Dianthus Therapeutics' Non Operating Income stood at $577000.0 in 2022, then soared by 314.73% to $2.4 million in 2023, then jumped by 45.26% to $3.5 million in 2024, then rose by 1.35% to $3.5 million in 2025.
• Business Quant data shows DNTH's Non Operating Income at $3.5 million in Q3 2025, $3.3 million in Q2 2025, and $3.7 million in Q1 2025.